170 related articles for article (PubMed ID: 12957661)
1. Inhibition of aromatase: insights from recent studies.
Santen RJ
Steroids; 2003 Sep; 68(7-8):559-67. PubMed ID: 12957661
[TBL] [Abstract][Full Text] [Related]
2. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
[TBL] [Abstract][Full Text] [Related]
3. Are aromatase inhibitors superior to antiestrogens?
Howell A; Buzdar A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):237-47. PubMed ID: 15860266
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
5. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
Jordan VC; Brodie AM
Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of aromatase inhibitors.
Miller WR; Jackson J
Expert Opin Investig Drugs; 2003 Mar; 12(3):337-51. PubMed ID: 12605559
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with Aromatase Inhibitors in Postmenopausal Women with Breast Cancer and the Possibility of Influencing Side Effects].
Krásenská M
Klin Onkol; 2016; 29 Suppl 3():S39-49. PubMed ID: 28118723
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibition and antiestrogen therapy in early breast cancer treatment and chemoprevention.
Ingle JN
Oncology (Williston Park); 2001 May; 15(5 Suppl 7):28-34. PubMed ID: 11396362
[TBL] [Abstract][Full Text] [Related]
9. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
Goss PE; Strasser K
Drugs; 2002; 62(6):957-66. PubMed ID: 11929341
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors: possible future applications.
Karaer O; Oruç S; Koyuncu FM
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):699-706. PubMed ID: 15255840
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of aromatase inhibitors in breast cancer.
Mokbel K
Int J Clin Oncol; 2002 Oct; 7(5):279-83. PubMed ID: 12402060
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens.
Sabnis G; Goloubeva O; Jelovac D; Schayowitz A; Brodie A
Clin Cancer Res; 2007 May; 13(9):2751-7. PubMed ID: 17473209
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors: rationale for use following antiestrogen therapy.
Yue W; Santen RJ
Semin Oncol; 1996 Aug; 23(4 Suppl 9):21-7. PubMed ID: 8824461
[TBL] [Abstract][Full Text] [Related]
15. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
[TBL] [Abstract][Full Text] [Related]
16. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.
Michaud LB; Buzdar AU
Drugs Aging; 2000 Apr; 16(4):261-71. PubMed ID: 10874521
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors: a new paradigm in breast cancer treatment.
Narashimamurthy J; Rao AR; Sastry GN
Curr Med Chem Anticancer Agents; 2004 Nov; 4(6):523-34. PubMed ID: 15579017
[TBL] [Abstract][Full Text] [Related]
18. Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast.
Kuerer HM; Buzdar AU; Singletary SE
J Surg Oncol; 2001 Jun; 77(2):139-47. PubMed ID: 11398169
[TBL] [Abstract][Full Text] [Related]
19. Focus on anastrozole and breast cancer.
Mokbel K
Curr Med Res Opin; 2003; 19(8):683-8. PubMed ID: 14687437
[TBL] [Abstract][Full Text] [Related]
20. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer?
Wu K; Brown P
J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
